Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Pivot Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Target Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Query: UMLS:C0026850 (
muscular dystrophy
)
5,870
document(s) hit in 31,850,051 MEDLINE articles (0.00 seconds)
Muscular dystrophy
requires cautious administration of muscle relaxants due to variable sensitivity and prolonged effects. A 43-year-old man with
muscular dystrophy
was scheduled for open reduction and internal fixation under general anesthesia. Following patient's
TOF
ratio with the muscle relaxation monitor, 80 minutes after rocuronium bromide (Rb) administration, we found that
TOF
ratio was over 0.9. We used sugammadex 4 mg x kg(-1) to reverse Rb-induced neuromuscular block, and then extubated. There was no clinical adverse effect on his muscular function and no respiratory distress after the use of sugammadex in the postoperative phase. Reversal of Rb-induced neuromuscular block by sugammadex in a patient with
muscular dystrophy
is efficient and safe.
...
PMID:[Successful use of sugammadex in a muscular dystrophy patient]. 2211 67